Gaining high throughput without compromising data quality

Teva Pharmaceuticals’ Analytical Development lab needed a higher-throughput capillary electrophoresis (CE) solution to support stability testing, process development and formulation for quality control (QC).

This case study discusses the considerations to make when moving from the SCIEX PA 800 Plus system to the SCIEX BioPhase 8800 system in development labs while ensuring method transfer to QC labs. Plus, learn of Teva's plans to implement the BioPhase 8800 system for its clinical phase programs.